跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VYNDAQEL SOFT GELATIN CAPSULE 20MG - HSA Drug Approval Details
Approvals
/
HSA
/
VYNDAQEL SOFT GELATIN CAPSULE 20MG
Approved
STANDARD
VYNDAQEL SOFT GELATIN CAPSULE 20MG
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
23378dc4fe6cbd29
Company
Unknown
Type
Standard
Approval Details
Approval Id
23378dc4fe6cbd29
Drug Name
VYNDAQEL SOFT GELATIN CAPSULE 20MG
Active Ingredients
Tafamidis 12.2mg eqv Tafamidis Meglumine
20mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
23378dc4fe6cbd29
Type
Standard
Back to HSA Approvals